The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 05, 2019

Filed:

Mar. 29, 2016
Applicant:

The Nemours Foundation, Jacksonville, FL (US);

Inventor:

Zhengyu Ma, Garnet Valley, PA (US);

Assignee:

The Nemours Foundation, Jacksonville, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C07K 14/725 (2006.01); C12N 5/0783 (2010.01); C07K 16/28 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); C07K 14/7051 (2013.01); C07K 14/7056 (2013.01); C07K 16/2809 (2013.01); C07K 16/2818 (2013.01); C07K 16/2878 (2013.01); C12N 5/0636 (2013.01); C07K 2317/14 (2013.01); C07K 2317/52 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/75 (2013.01);
Abstract

A chimeric antigen receptor (CAR) contains a human FcεRIα extracellular domain or a mutant FcεRIα extracellular domain that has a reduced binding affinity for human IgE compared to wild type human FcεRIα extracellular domain. The CAR further contains an intracellular signaling domain comprising at least one immunoreceptor-based activation motif (ITAM). The CAR may further comprise a costimulatory signaling domain, such as an intracellular domain of at least one of the costimulatory molecules 4-1BB, CD27, CD28, CD134 or ICOS. T cells transduced with vectors encoding the CAR are used in CAR-based adoptive T-cell therapy for targeting IgE-expressing B cells and treating IgE-mediated allergic diseases.


Find Patent Forward Citations

Loading…